This compound is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a benzyl and ethyl group on a piperazine ring, makes it a valuable intermediate in the development of drugs targeting the central nervous system, particularly those with receptor-specific activity. It is often employed in the preparation of compounds with potential antipsychotic, antidepressant, or analgesic properties. Additionally, its chiral nature allows for the creation of enantiomerically pure drugs, which can enhance efficacy and reduce side effects. Researchers also explore its use in designing novel therapeutic agents for neurological disorders due to its ability to interact with neurotransmitter systems.